KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Profit After Tax (2016 - 2025)

Historic Profit After Tax for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $32.9 million.

  • National Health Investors' Profit After Tax rose 1514.37% to $32.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.3 million, marking a year-over-year increase of 1614.26%. This contributed to the annual value of $138.0 million for FY2024, which is 171.83% up from last year.
  • According to the latest figures from Q3 2025, National Health Investors' Profit After Tax is $32.9 million, which was up 1514.37% from $37.0 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Profit After Tax registered a high of $43.2 million during Q4 2024, and its lowest value of $1.9 million during Q4 2022.
  • Over the past 5 years, National Health Investors' median Profit After Tax value was $32.9 million (recorded in 2025), while the average stood at $29.3 million.
  • Per our database at Business Quant, National Health Investors' Profit After Tax tumbled by 8248.52% in 2021 and then soared by 162012.88% in 2023.
  • National Health Investors' Profit After Tax (Quarter) stood at $6.5 million in 2021, then plummeted by 71.36% to $1.9 million in 2022, then surged by 1620.13% to $32.0 million in 2023, then soared by 34.94% to $43.2 million in 2024, then decreased by 24.0% to $32.9 million in 2025.
  • Its Profit After Tax stands at $32.9 million for Q3 2025, versus $37.0 million for Q2 2025 and $34.2 million for Q1 2025.